InvestorsObserver
×
News Home

Is Abbott Laboratories (ABT) Stock Trading Below Fair Value?

Tuesday, November 28, 2023 03:56 PM | InvestorsObserver Analysts

Mentioned in this article

Is Abbott Laboratories (ABT) Stock Trading Below Fair Value?

InvestorsObserver gives Abbott Laboratories (ABT) a weak valuation score of 38 from its analysis. The proprietary scoring system considers the underlying health of a company by analyzing its stock price, earnings, and growth rate. ABT currently holds a better value than 38% of stocks based on these metrics. Long term investors focused on buying-and-holding should find the valuation ranking system most relevant when making investment decisions.

Valuation Rank - 38
ABT gets a 38 Valuation Rank today. Find out what this means to you and get the rest of the rankings on ABT!

Metrics Analysis

ABT has a trailing twelve month Price to Earnings (PE) ratio of 34.6. The historical average of roughly 15 shows a poor value for ABT stock as investors are paying higher share prices relative to the company's earnings. ABT's high trailing PE ratio shows that the firm has been trading above its fair market value recently. Its trailing 12-month earnings per share (EPS) of 2.94 does not justify the stock's current price. However, trailing PE ratios do not factor in the company's projected growth rate, resulting in many newer firms having high PE ratios due to high growth potential enticing investors despite inadequate earnings.
ABT has a 12 month forward PE to Growth (PEG) ratio of 2.57. Markets are overvaluing ABT in relation to its projected growth as its PEG ratio is currently above the fair market value of 1. 2.94's PEG comes from its forward price to earnings ratio being divided by its growth rate. PEG ratios are one of the most used valuation metrics due to its incorporation of more company fundamentals metrics and a focus on the firm's future rather than its past.

Summary

All together these valuation metrics paint a pretty poor picture for ABT at its current price due to a overvalued PEG ratio despite strong growth. The PE and PEG for ABT are worse than the average of the market resulting in a valuation score of 38. Click Here to get the full Report on Abbott Laboratories (ABT) stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App